KTKyle Tofflemire

Kyle Tofflemire

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kyle Tofflemire has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Elizabeth M. Whitley

    Pathogenesis LLC Gainesville FL 32614 USA

    2 shared publications
  • Gil Ben‐Shlomo

    Department of Veterinary Clinical Sciences Iowa State University College of Veterinary Medicine Ames Iowa 50011 USA

    2 shared publications
  • Allison M. Flinn

    Department of Veterinary Clinical Sciences, Iowa State University College of Veterinary Medicine, Ames, IA, 50011, USA

    1 shared publication
  • Angela Griggs

    Department of Veterinary Clinical Sciences Iowa State University College of Veterinary Medicine Ames Iowa 50011 USA

    1 shared publication
  • Angela N. Griggs

    Department of Veterinary Clinical Sciences, Iowa State University College of Veterinary Medicine, Ames, IA, 50011, USA

    1 shared publication
  • Caroline Betbeze

    Veterinary Specialty Center of Tucson, 4909 N. La Canada Drive, Tucson, AZ 85704‐1507, USA

    1 shared publication

Latest Publications

  • Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study

    by Kyle Tofflemire, Elizabeth M. Whitley, Rachel Allbaugh, Gil Ben‐Shlomo, Angela Griggs, Travis Strong, R. David Whitley

    Objective: To evaluate the effect of topical ophthalmic 0.005% latanoprost alone and in combination with 0.1% diclofenac on healthy horses.Animals studied: Twelve healthy adult horses.Procedures: A randomized, masked crossover design was used with horses divided into three groups for once daily treatment in one randomly selected eye. For arm 1 of the study, Group D (n= 3) received 0.1% diclofenac, Group L (n= 3) received 0.005% latanoprost, and GroupDL(n= 6) received 0.005% latanoprost and 0.2 ml of 0.1% diclofenac. For arm 2 of the study, horses from Group D and L were placed into GroupDLand horses from GroupDLwere placed into either Group D or L. Evaluations of intraocular pressure (IOP), vertical pupil diameter, aqueous flare, conjunctival hyperemia, epiphora, blepharospasm, and blepharoedema were performed 4 times daily on days 1 and 2 (baseline), days 3 to 7 (arm 1 treatment), days 8 to 11 (washout), days 12 to 16 (arm 2 treatment), and days 17 and 18 (return to baseline).Results: During the treatment period, significant reduction inIOPand vertical pupil diameter occurred in treated eyes of Groups L andDL, but not Group D. These variables did not differ significantly between Groups L andDL. Blepharospasm, blepharoedema, epiphora, and conjunctival hyperemia scores were significantly higher in Group L than in Groups D andDL.Conclusions: Latanoprost reducedIOPin healthy horses and signs of drug‐induced discomfort were mitigated by concurrent use of diclofenac.


  • Effect of topical ophthalmic dorzolamide(2%)–timolol(0.5%) solution and ointment on intraocular pressure in normal horses

    by Kyle L. Tofflemire, Elizabeth M. Whitley, Allison M. Flinn, Valerie L. Dufour, Gil Ben‐Shlomo, Rachel A. Allbaugh, Angela N. Griggs, Chimene S. Peterson, David R. Whitley

    Objective To compare the effect of commercially available solution and compounded ointment formulations of dorzolamide(2%)–timolol(0.5%) on intraocular pressure (IOP) of normal horses. Animals Eighteen clinically normal horses. Procedures A randomized, masked prospective design was used with horses divided into two equal groups. One eye of each horse was selected for topical ophthalmic treatment with either 0.2 mL of dorzolamide(2%)–timolol(0.5%) solution or 0.2 g of dorzolamide(2%)–timolol(0.5%) ointment every 12 h for 5 days. The contralateral eye of horses in both groups was untreated. Rebound tonometry was performed every 6 h starting 2 days prior to and ending 2 days after the treatment period. Results The mean IOP reduction in eyes treated with the solution or ointment formulations was 13%. Untreated eyes in both groups experienced a lesser but still statistically significant reduction in IOP. The IOP values did not return to baseline within 48 h of the last treatment. Conclusions and Clinical Relevance The commercially available solution and compounded ointment formulations of ophthalmic dorzolamide(2%)–timolol(0.5%) had similar effects on IOP in normal horses. Persistent IOP reduction following cessation of treatment may indicate prolonged drug effect or acclimation of horses to tonometry.


  • Three cases of feline ocular coccidioidomycosis: presentation, clinical features, diagnosis, and treatment

    by Kyle Tofflemire, Caroline Betbeze

    To describe clinical and diagnostic features of ocular coccidioidomycosis in cats and the response to fluconazole and anti-inflammatory therapy. Three cats with naturally acquired coccidioidomycosis. Cats were treated with topical or systemic corticosteroids and systemic fluconazole, an antifungal of unproven efficacy against feline ocular coccidioidomycosis. Two cats presented for periocular swellings, either subpalpebral or periorbital, with systemic signs including weight loss, unkempt hair coat, and lethargy. One cat presented for apparent blindness with no systemic signs. Clinical ophthalmologic abnormalities were bilateral in each cat and included hyperemic, conjunctival masses, fluid-filled periorbital swellings, granulomatous chorioretinitis, nonrhegmatogenous retinal detachments, and anterior uveitis. Cats were diagnosed with coccidioidomycosis using a combination of clinical findings, serology and, in two cases, visualization of Coccidioides spherules by either aspiration cytology or biopsy. Active anterior uveitis and periocular swelling were resolved in all cats during treatment. Chorioretinal granulomas, although persistent, significantly decreased in size. Coccidioidomycosis should be considered as a differential diagnosis for cats with a travel history to the southwestern United States that demonstrate periocular swelling, anterior uveitis, or granulomatous chorioretinitis, with or without evidence of systemic disease. Aspiration cytology or biopsy of suspicious conjunctival or skin lesions, if present, may aid in diagnosis. A combination of corticosteroids and fluconazole may be effective in treating ocular coccidioidomycosis, although chorioretinal granulomas may persist and long-term fluconazole therapy may be necessary.